chr1-86360451-G-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001366781.1(ODF2L):c.1142C>A(p.Thr381Asn) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000769 in 1,560,088 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001366781.1 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
ODF2L | NM_001366781.1 | c.1142C>A | p.Thr381Asn | missense_variant | 11/17 | ENST00000460698.7 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
ODF2L | ENST00000460698.7 | c.1142C>A | p.Thr381Asn | missense_variant | 11/17 | 5 | NM_001366781.1 | P4 |
Frequencies
GnomAD3 genomes AF: 0.0000461 AC: 7AN: 151902Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000122 AC: 3AN: 245380Hom.: 0 AF XY: 0.0000151 AC XY: 2AN XY: 132740
GnomAD4 exome AF: 0.00000355 AC: 5AN: 1408186Hom.: 0 Cov.: 24 AF XY: 0.00000426 AC XY: 3AN XY: 703642
GnomAD4 genome AF: 0.0000461 AC: 7AN: 151902Hom.: 0 Cov.: 32 AF XY: 0.0000539 AC XY: 4AN XY: 74170
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Feb 28, 2023 | The c.1229C>A (p.T410N) alteration is located in exon 12 (coding exon 11) of the ODF2L gene. This alteration results from a C to A substitution at nucleotide position 1229, causing the threonine (T) at amino acid position 410 to be replaced by an asparagine (N). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at